Article
Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activity.
The Journal of biological chemistry - 1 Jun 2023
Hollander Michael J, Malaker Stacy A, Riley Nicholas M, Perez Idalia, Abney Nayla M, Gray Melissa A, Maxson Julia E, Cochran Jennifer R, Bertozzi Carolyn R
Abstract excerpt
The colony-stimulating factor 3 receptor (CSF3R) controls the growth of neutrophils, the most abundant type of white blood cell. In healthy neutrophils, signaling is dependent on CSF3R binding to its ligand, CSF3. A single amino acid mutation in CSF3R, T618I, instead allows for constitutive, ligand-independent cell growth and leads to a rare type of cancer called chronic neutrophilic leukemia. However, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
